Skip to main content



Clinical courses


Clinical research courses

  • Capryloyl glycine - Multifunctional active for Cosmetics

    Vinay KumarVinay Kumar Singh. 
    Kumar Organic Products Research Centre Pvt. Ltd.,
    Email :

  • Google wants to index your DNA
    A new DNA search tool, akin to a Google for genetic material, shows great potential, as reported by its Swiss creators. In a groundbreaking study, they managed to index 10 percent of the globes known DNA, RNA, and protein sequences, suggesting that this approach could feasibly expand to encompass the entirety of biological sequence data.
  • Pharmacists prove effective, less costly care option for minor illnesses

    Greater use of pharmacists to treat minor illnesses could potentially save millions of dollars in health care costs, according to new research led by Washington State University. The findings also indicate a way to improve healthcare access by expanding availability of pharmacists’ clinical services including prescribing medications, amid an ongoing shortage of primary care providers.

  • Neurocosmetics

    Vinay KumarVinay Kumar Singh. 
    Kumar Organic Products Research Centre Pvt. Ltd.,
    Email :

  • MHRA recall classification

    The table below explains the new Medicines Recall and Notification classifications and the associated defect risk classification.

    Medicines Recall/Notification Classification : Defect risk classification

    National Patient Safety Alert (NatPSA) equivalent to Class 1 Medicines Recall : The defect presents a risk of death or disability. These alerts will be issued via CAS as National Patient Safety Alerts and will be published on the MHRA website.

  • Caprylhydroxamic acid (KOPSYM)- Dual active for Cosmetics
    Caprylhydroxamic acid is a synthetic chelating agent that helps protect cosmetic formulas from destabilizing metal ions. It also works as a preservative, having the ability to prevent mold growth in water-based formulas. This ingredient has great flexibility since it works in all types of cosmetic formulas, including waterless (anhydrous) and its efficacy is not pH-dependent.
  • Preventive angioplasty does not improve prognosis

    For heart attack patients, treating only the coronary artery that caused the infarction works just as well as preventive balloon dilation of the other coronary arteries, according to a new large study by researchers at Karolinska Institutet and others. The results are published in the New England Journal of Medicine.

  • Discovery of how limiting damage from an asthma attack could stop disease

    Scientists at King’s have discovered a new cause for asthma that sparks hope for treatment that could prevent the life-threatening disease.

  • 100 Rs tablet prevents spread of cancer, breakthrough research by Indian Scientists

    The breakthrough research by TATA memorial centre scientists who have developed a tablet which reduces side effects of cancer treatment and prevent resurgence or relapse of cancer said Dr Rajendra Badwe, Director of the Tata Memorial Centre in an interview with NDTV. The said tablet will be available at an affordable price of Rs. 100 a tablet.

  • First Indian discovered antibiotic gets FDA approval, took 16 years to reach market

    Orchid Pharma, based in Chennai, India, has received approval by the United States Food and Drug Administration (USFDA) for its novel invention, ‘Enmetazobactam’. This development comes in close succession to the recent recommendation for approval by the European Medicines Agency (EMA). Enmetazobactam is the first completely invented-in-India Beta Lactamase Inhibitor.

Subscribe to Pharmapedia